Conference Online
Plenary Speakers

Biophotonics: Sustaining the Endless Frontier
Eugene Arthurs, PhD, CEO, SPIE – The International Society for Optics and Photonics, USA

Eugene G. Arthurs joined SPIE staff as Executive Director in November 1999. Prior to this he was President and CEO of Cleveland Crystals Inc. (CCI) He joined CCI, a closely held company, in 1997 and after reorganizing the company he marketed and sold it at the end of 1998. In 1980 he joined Quantronix Corporation in New York, leading laser system development for medical, industrial and scientific applications, and then managing its business for the semiconductor equipment market. From 1983 to 1997, Eugene was with Oriel Corporation in Connecticut, initially as Vice President of Technology and Marketing and from 1991, as President. Oriel, originally a privately held corporation, was acquired by a venture capital company in 1987. He changed the business of Oriel to emphasize systems and instruments and in 1996 ThermoElectron Corp. acquired an increasingly profitable Oriel. Eugene became involved in Thermo’s growth-by-acquisition activities. During his time at Oriel, he played an active role on the Boards of Oriel Scientific Ltd., (London, UK), LOT Oriel GmBH, (Darmstadt, Germany) and he was a founder of Andor Technology Ltd. (Belfast, N.Ireland) a company initially owned mostly by Oriel. Eugene received his B.Sc. (1st class honours) in 1972 in Physics, and his Ph.D. in 1975 in Applied Physics from Queens University Belfast, N. Ireland. His Ph.D. research was in generation and measurement of tunable ultrashort pulses. In 1973, he taught the M.Sc. class in optoelectronics at Queens while continuing his research. He then moved to Imperial College in London where he conducted U.S. Air Force sponsored research on lasers. An SPIE member from 1972 or so, Eugene has been active in the American Society for Lasers in Medicine of which he was a founding member, the Council for Optical Radiation Measurement, The International Year of Light Steering Committee, and the OSA at a local and national level. He is currently a member of SPIE, OSA, IEEE, AAAS, and ASAE. He is a member of the boards of Edmund Optics and the Alliance for Science & Technology Research in America, the U.S. National Photonics Initiative Steering Committee, the Advisory Boards to the Canadian Institute for Photonics Innovation and the Scottish University Physics Alliance, and he is also a member of the Photonics21 Board of Stakeholders.

Life and Science Aboard the International Space Station
Dr Stephen K Robinson, Professor and Chair, UC Davis Department of Mechanical and Aerospace Engineering and Director, UC Davis Center for Human/Robotics/Vehicle Integration and Performance (and former NASA Astronaut), USA

Before joining the faculty at UC Davis in 2012, Stephen Robinson spent 37 years at NASA, where he served as a research scientist, manager, engineer, and astronaut. Robinson now directs the UC Davis Center for Human/Robotic/Vehicle Integration and Performance, where students pursue research in: Human/Systems Engineering, Human Spaceflight, Aviation Safety, Human/Robotic Integration, and UAV applications. He also serves as Chair of the Mechanical and Aerospace Engineering Department.

As a NASA Astronaut, Dr. Robinson flew on four space shuttle missions, including three spacewalks, and has extensive expertise in spacecraft systems, operational safety, space robotics, aerodynamics, and fluid physics. He has received numerous awards, including NASA’s highest honor, the Distinguished Service Medal. Robinson is a UC Davis alumnus in Mechanical and Aeronautical Engineering (B.S., 1978) and received his M.S. and Ph.D. in turbulence physics from Stanford University in Mechanical and Aero/Astro Engineering (1986, 1990).



Sessions and Session Leaders

Session 1: How to Set a Big Picture Biophotonics Research Agenda
Laura Marcu, PhD, University of California at Davis, USA

Laura Marcu is Professor of Biomedical Engineering and Neurological Surgery at the University of California at Davis. She received her Ph.D. in biomedical engineering in 1998 from the University of Southern California, Los Angeles. Prior of joining UC Davis in 2006, she served as the Director of the Biophotonics Research Laboratory at Cedars-Sinai Medical Center, Los Angeles. Her research interest is in the area of biomedical optics, with a particular focus on research for development of fluorescence lifetime techniques for tissue diagnostics. Her applied research targets solutions for main societal problems including the atherosclerotic cardiovascular disease and cancer. She is a co-editor of the first textbook in “Fluorescence Lifetime Spectroscopy and Imaging: Principles and Applications in Biomedical Diagnostics. She served (2007-2010) on the Board of Directors of the Biomedical Engineering Society in the USA. She is the recipient of a Leverhulme Trust Visiting Professorship at the Imperial College London (Physics). Currently, she serves as Associate Editor for Biomedical Optics Express and as member of the Editorial Board for Journal of Biophotonics. She is an elected Fellow of four prestigious professional societies – the American Institute for Medical and Biological Engineers (AIMBE), the Biomedical Engineering Society (BMES), the Optical Society (OSA), and the International Society for Optics and Photonics (SPIE).

Invited speakers:
Stephen Boppart, PhD, MD, University of Illinois at Urbana-Champaign, USA
Mark Hutchinson, PhD, University of Adelaide, Australia

Brian WilsonPhD, Princess Margaret Cancer Centre, University of Toronto, Canada
Jürgen Popp, PhD, Leibniz Institute of Photonic Technology, Germany

Session 2: In Vivo Non-Invasive Human Retinal Blood Vessel and Flow Imaging: Biophotonic Advances and Clinical Applications 
Fred Chen
, MD, Lions Eye Institute, Australia

Dr Fred K Chen is a surgeon-scientist at the Lions Eye Institute. He returned to Perth in 2010 after advanced training in medical and surgical retina at Moorfields Eye Hospital and completing a PhD in retinal pigment epithelium transplantation for macular degenerations at the University College of London Institute of Ophthalmology. He is currently a consultant vitreoretinal surgeon and the Director of Ocular Tissue Engineering Laboratory at Lions Eye Institute. He is main clinical and translational research interests are treatment clinical trials endpoint validation, randomized controlled trials of new therapies for macular degeneration, high resolution non-invasive cellular and vascular imaging of the retina, monitoring of inherited retinal disease progression and application of stem cell technology in developing personalised medicine through induced pluripotent stem cells. He serves on the Board of Directors for Ophthalmic Research Institute of Australia and is funded by the Australian NH&MRC.

Invited speakers:
Andrew Metha
, University of Melbourne, Australia
Chandra Balaratnasingam, Lions Eye Institute, Australia

Session 3: Tumour Margin Identification: Critiquing Technologies
Stephen A. Boppart
, PhD, MD, University of Illinois at Urbana Champaign, USA

Stephen A. Boppart was born in Harvard, IL, in 1968. He received the B.S. degree in electrical and bioengineering and the M.S. degree in electrical engineering from the University of Illinois at Urbana-Champaign, Urbana, IL, in 1990 and 1991, respectively, the Ph.D. degree in electrical and medical engineering from the Massachusetts Institute of Technology, Cambridge, in 1998, and the M.D. degree from Harvard Medical School, Boston, MA, in 2000.

He was a Research Scientist with the Air Force Laser Laboratory, Brooks Air Force Base, San Antonio, TX, where he was engaged in research on developing national (ANSI) and Air Force laser safety standards. Since 2000, he has been with the University of Illinois at Urbana-Champaign, Urbana, from where he completed residency training in internal medicine in 2005. He is currently an Able Bliss Professor of Engineering in the departments of Electrical and Computer Engineering, Bioengineering, and Medicine, the Head of the Biophotonics Imaging Laboratory, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, and also the Director of Imaging at Illinois. He has authored or coauthored more than 300 invited and contributed publications, and more than 670 invited and contributed presentations. He holds more than 40 patents, filed or pending. His research interests include the development of novel optical imaging technologies for biological and medical applications, with particular emphasis on translating these to clinical applications.

Dr. Boppart is a Fellow of IEEE, AAAS, OSA, SPIE, and AIMBE. He is also a member of the Biomedical Engineering Society, the American Association for Cancer Research, and the American Medical Association. He was named one of the top 100 innovators in the world by the Technology Review Magazine for his research in medical technology, and received the IEEE Engineering in Medicine and Biology Society Early Career Achievement Award. He received the Paul F. Forman Engineering Excellence Award from the Optical Society of America for dedication and advancement in undergraduate research education, and recently, the international Hans Sigrist Prize for his work in diagnostic laser medicine.

Invited speakers:
J. Quincy Brown
, PhD, Tulane University, USA
Christobel M. Saunders, MD, The University of Western Australia, Australia
Laura Marcu, PhD, University of California Davis, USA
Esther Kho, Netherlands Cancer Institute, Netherlands

Camile Farah
, The University of Western Australia, Australia

Session 4: Hot Posters
Philip Wijesinghe
, WA OSA Student Chapter President, Australia and Danuta Sampson, Lions Eye Institute, Australia

Philip Wijesinghe received a B.Eng. in Electrical and Electronic Engineering and a B.Sc. in Physiology from The University of Western Australia, where he is currently completing his PhD as part of the Optical+Biomedical Engineering Laboratory and BRITElab, Harry Perkins Institute of Medial Research. His research focuses on optical elastography, the measurement and understanding of the mechanical properties of tissue and their role in disease processes. His research interests lie across a spectrum of physics, engineering and biology, particularly in technique development, signal processing and mechanobiology. Beyond research, he is heavily engaged in science outreach. He is the current President of the OSA Student Chapter of The University of Western Australia, and an active member of Western Australia’s DIYbio community. He hopes to make science more accessible by removing some of the typical complexity, jargon and cost associated with academia.

Session 5: Challenges in Translation: Models to Promote Translation
Jürgen Popp
, PhD, Leibniz Institute of Photonic Technology, Germany

Jürgen Popp studied chemistry at the universities of Erlangen and Würzburg. After his PhD in Chemistry he joined Yale University for postdoctoral work. He subsequently returned to Würzburg University where he finished his habilitation in 2002. Since 2002 he holds a chair for Physical Chemistry at the Friedrich-Schiller University Jena. Since 2006 he is also the scientific director of the Leibniz Institute of Photonic Technology, Jena. His research interests are mainly concerned with biophotonics. In particular his expertise in the development and application of innovative Raman techniques for biomedical diagnosis should be emphasized. He has published more than 630 journal papers and has been named as an inventor on 12 patents in the field of spectroscopic instrumentation. He is founding editor and Editor-in-Chief of the Journal of Biophotonics. In 2012, he received an honorary doctoral degree from Babeş-Bolyai University in Cluj-Napoca, Romania. Professor Jürgen Popp is the recipient of the 2013 Robert Kellner Lecture Award and the prestigious 2016 Pittsburgh Spectroscopy Award. In 2016 he was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

Invited speakers:
Dennis Matthews
, PhD, University of California (Davis), USA 
Brian Wilson, PhD, Princess Margaret Cancer Centre, University of Toronto, Canada
Alfredo Martinez-Coll, MTPConnect, Australia

Session 6: SPARK Co-Lab, Training People to Identify a Commercial Pathway for Unmet Needs

SPARK Co-Lab is a collaboration between the universities and medical research institutes in Western Australia in affiliation with Stanford University's SPARK program. It provides an ideas design course, mentoring, project management and ecosystem building events to translate medical discoveries to commercial outcomes (start-ups, licensing and clinical trials). The SPARK Design course facilitates teams to create medical devices from needs identification in clinical areas to ideation. It then develops business strategy to implement the concept and facilitates investment in the team's start-up. This session will present part of the process and discuss a case study of a recent alumni team, who is collaborating with biophotonics engineers in how they discovered their clinical need and are executing their solution through the translational pathway. An exercise in brainstorming will also give core skills to participants when facing challenges in ideation.

Peter Santa Maria, MD, The University of Western Australia, Australia

Dr Santa Maria is a clinician scientist at The University of Western Australia after moving from Stanford University in 2015. Clinically he is an ENT surgeon with a sub specialty in Neurotology and skull base surgery. His focus is on translational medicine and commercializing medtech and biopharma. Currently he is a director at SPARK Co-Lab and one of the Founders and Chief of the scientific advisory board for Auration Biotech (Hearing Pharmaceuticals) as well as Founder and Chief Medical Officer for Flo-therm (Perioperative warming device. His basic science research efforts focused on tympanic membrane wound healing. Since then he has developed novel animal models to study chronic tympanic membrane perforation and chronic suppurative otitis media. His novel research into a treatment for tympanic membrane perforations was accelerated through the SPARK program at Stanford University into Auration Biotech. On the medical device side he, along with a group in Stanford's Biodesign class, developed a novel medical device for maintaining perioperative temperature. He acted as Principal Investigator for this device in its first in man trial at Stanford University. Based on the success of this trial the device is now being developed within Flo-therm. He also is an active consultant for a number of Bay Area medical device companies. As a director of SPARK Co-Lab he is dedicated to medical discovery and translation through to the clinical stage.

Invited speakers:
Dylan Beinart
, The University of Western Australia, Western Australia
Sarah McGarry, PhD, Princess Margaret Hospital for Children and Fiona Stanley Hospital, Western Australia
Arjun Kaushik, The University of Western Australia, Western Australia
Ming Yew, MD, St John of God’s Hospital, Murdoch, Western Australia
Hsern Ern Tan, MD, Ear Science Institute of Australia

Session 7: Neurophotonics
Anita Mahadavan-Jansen
, PhD, Vanderbilt University, USA

Dr Mahadevan-Jansen translates optical techniques for clinical detection of tissue physiology and pathology. Her primary research at the Vanderbilt Biophotonics Center, is to investigate the applications of optical spectroscopies and imaging for disease diagnosis and guidance of therapy. She received her bachelor’s and master’s degrees in Physics from the University of Bombay (Mumbai), India, and a master’s and PhD degrees in Biomedical Engineering from the University of Texas at Austin. She joined the Vanderbilt engineering faculty in 1996. She is currently the Orrin H. Ingram Professor of Biomedical Engineering at Vanderbilt University and holds a secondary appointment in the Department of Neurological Surgery. She serves as Director of the Vanderbilt Biophotonics Center, Director of the Vanderbilt branch of the Center for Integration of Research in Teaching and Learning (CIRTL), an NSF funded 22-institution center as well as Director of Undergraduate Studies for the Department of Biomedical Engineering at Vanderbilt University.

Dr Mahadevan-Jansen is an associate editor of Neurophotonics as well as Applied Spectroscopy and serves as a reviewer of more than 20 journals and as chair of numerous professional conferences. She has authored over 75 peer-reviewed publications and is funded by the NIH, NSF, DOD and AFOSR for her research. She is currently on the Board of Directors of the International Society for Optical Engineering (SPIE) and is a fellow of SPIE as well as the American Institute of Medical and Biological Engineering (AIMBE).

Invited speakers:
Paul Stoddart
, PhD, Swinburne University of Technology, Australia
Mark Hutchinson, PhD, University of Adelaide, Australia

Session 8: Radical New Ideas in Biophotonics
Kishan Dholakia
, PhD, University of St Andrews, Scotland

Kishan Dholakia is Professor of Physics at the University of St Andrews Scotland and an honorary adjunct Professor at the centre for Optical Sciences at the University of Arizona, USA and visiting Professor at Chiba University, Japan. He heads the Optical Manipulation Group who work on a wide range of topics based on light. This includes advanced imaging for neuroscience and cancer diagnosis, beam shaping and optical manipulation. He has published over 275 refereed journal papers, with many in Nature/Science journals and has around 20,000 citations and a h-index of 73. His work has led to a citation in the Guinness book of Records for the world’s fatest man-made rotation. He was elected to the position of Fellow of the Royal Society of Edinburgh in 2007 and is fellow of the Optical Society (OSA) and SPIE. He won the European Optics Prize in 2003 and in 2008 he received a Royal Society Wolfson Merit Award. He is the 2016 winner of the R.W. Wood Prize of the Optical Society.

Invited speakers:
Chris Xu
, Cornell University, USA
Carola Thoni, PhD Heidelberg University, Monash Micro Imaging Affiliate
Tomasz Tkaczyk, PhD, Rice University, USA

Post-Conference Workshop: Publishing in Biophotonics: Trends, Issues and Opportunities
Eric Pepper
, Director of Publishing, SPIE
Christoph Hitzenberger, PhD, Editor-in-Chief, Biomedical Optics Express
Jürgen Popp, PhD, IPHT, Germany 
Martin Delahunty, Global Director, Nature Partner Journals